Thomas Jiborn

923 total citations
16 papers, 453 citations indexed

About

Thomas Jiborn is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Thomas Jiborn has authored 16 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Thomas Jiborn's work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (7 papers) and Global Cancer Incidence and Screening (4 papers). Thomas Jiborn is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (7 papers) and Global Cancer Incidence and Screening (4 papers). Thomas Jiborn collaborates with scholars based in Sweden, United States and Iceland. Thomas Jiborn's co-authors include Anders Bjartell, Magnus Abrahamson, Åke Lundwall, Virgil Gadaleanu, Jonas Hugosson, Barbara Wegiel, Leo E. Otterbein, Leszek Helczynski, Stefan Carlsson and Jenny L. Persson and has published in prestigious journals such as PLoS ONE, European Urology and Urology.

In The Last Decade

Thomas Jiborn

14 papers receiving 446 citations

Peers

Thomas Jiborn

PRM

ONCOL

RHEUM

Masahiro Yashi Japan

Marcus V. Sadi Brazil

Masatoshi Muramoto Japan

Toyofusa Tobe Japan

Sheng-Chun Hung Taiwan

A. De La Taille France

Dennis L. Broyles United States

Keita Tamura Japan

Brigitte Brux Germany

Octavian Sabin Tătaru Romania

Masahiro Yashi Japan

Thomas Jiborn

244 ×0.8

PRM

148 ×1.2

ONCOL

132 ×1.6

63 ×0.8

RHEUM

64 ×1.0

Citations per year, relative to Thomas Jiborn Thomas Jiborn (= 1×) peers Masahiro Yashi

Countries citing papers authored by Thomas Jiborn

Since Specialization

Citations

This map shows the geographic impact of Thomas Jiborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Jiborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Jiborn more than expected).

Fields of papers citing papers by Thomas Jiborn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Jiborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Jiborn. The network helps show where Thomas Jiborn may publish in the future.

Co-authorship network of co-authors of Thomas Jiborn

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Jiborn. A scholar is included among the top collaborators of Thomas Jiborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Jiborn. Thomas Jiborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bratt, Ola, Salma Butt, Christer Carlsson, et al.. (2025). Swedish regional population-based organised prostate cancer testing: why, what and how?. Scandinavian Journal of Urology. 60. 97–104. 3 indexed citations

Wallström, Jonas, et al.. (2025). A Comparison of Magnetic Resonance Imaging Assessment and Biopsy Outcomes with and Without Central Review in Two Swedish Regional Organized Prostate Cancer Testing Programs. European Urology Open Science. 77. 32–38.

Jiborn, Thomas, Fredrik Jäderling, Anna Lantz, et al.. (2025). Incidental findings on prostate MRI in a population-based screening setting. Insights into Imaging. 16(1). 261–261.

Zackrisson, Sophia, et al.. (2024). A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing. Acta Oncologica. 63. 816–821. 2 indexed citations

Bengtsson, Johan, et al.. (2023). A pilot study of an organised population‐based testing programme for prostate cancer. British Journal of Urology. 133(1). 87–95. 13 indexed citations

Borg, Sixten, et al.. (2023). Implementation of the measure of case discussion complexity to guide selection of prostate cancer patients for multidisciplinary team meetings. Cancer Medicine. 12(14). 15149–15158. 3 indexed citations

Svensson, Linda, et al.. (2023). Men’s Perception of Being Invited for Prostate Cancer Testing and the Information About Its Pros and Cons—A Survey from Two Population-based Testing Programmes. European Urology Open Science. 52. 66–71. 8 indexed citations

Bratt, Ola, Rebecka Arnsrud Godtman, Thomas Jiborn, et al.. (2023). Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men. European Urology. 85(3). 207–214. 30 indexed citations

Wallström, Jonas, Johan Bengtsson, Thomas Björk‐Eriksson, et al.. (2022). Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme. European Urology Focus. 8(6). 1568–1574. 28 indexed citations

10.

Anand, Aseem, et al.. (2021). A retrospective study assessing the accuracy of [18F]–fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node dissection. Scandinavian Journal of Urology. 55(4). 293–297. 5 indexed citations

11.

Steineck, Gunnar, Anders Bjartell, Jonas Hugosson, et al.. (2014). Degree of Preservation of the Neurovascular Bundles During Radical Prostatectomy and Urinary Continence 1 Year after Surgery. European Urology. 67(3). 559–568. 96 indexed citations

12.

Wilderäng, Ulrica, Thomas Jiborn, Peter Wiklund, et al.. (2013). Interobserver variability in the pathological assessment of radical prostatectomy specimens: Findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study. Scandinavian Journal of Urology. 48(2). 160–167. 16 indexed citations

13.

Wegiel, Barbara, Thomas Jiborn, Magnus Abrahamson, et al.. (2009). Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways. PLoS ONE. 4(11). e7953–e7953. 60 indexed citations

14.

Jiborn, Thomas, Magnus Abrahamson, Virgil Gadaleanu, Åke Lundwall, & Anders Bjartell. (2006). Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation. British Journal of Urology. 98(1). 189–196. 29 indexed citations

15.

Jiborn, Thomas, Magnus Abrahamson, Johan Malm, et al.. (2004). Cystatin C Is Highly Expressed in the Human Male Reproductive System. Journal of Andrology. 25(4). 564–572. 34 indexed citations

16.

Jiborn, Thomas, et al.. (1998). Neuroendocrine Differentiation in Prostatic Carcinoma During Hormonal Treatment. Urology. 51(4). 585–589. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact